LUKE M. BESHAR - 10 Mar 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Director
Signature
/s/ Karen Deschaine, Attorney-in-fact
Issuer symbol
TARA
Transactions as of
10 Mar 2022
Net transactions value
+$44,555
Form type
4
Filing time
14 Mar 2022, 16:37:01 UTC
Previous filing
19 Nov 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Purchase $44,555 +10,000 +6% $4.46 178,000 10 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.